DEXTROMETHORPHANE ELERTE 1,5 mg/ml, sirop, AZD3470, AZD3470, Midazolam-ratiopharm® 2 mg/ml orale Lösung
PRIMROSE D9970C00001
Phase 1 small_molecule active
Quick answer
DEXTROMETHORPHANE ELERTE 1,5 mg/ml, sirop, AZD3470, AZD3470, Midazolam-ratiopharm® 2 mg/ml orale Lösung for Advanced/metastatic solid tumors that are MTAP deficient. is a Phase 1 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Advanced/metastatic solid tumors that are MTAP deficient.
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active